Awakn Axonklinikken

Axonklinikken was a Norway-based ketamine-assisted psychotherapy clinic focused on mental health and addiction treatment. In 2021, the company was acquired by Awakn Life Sciences and was announced to be renamed as Awakn Clinics Oslo AS as part of Awakn's Nordic clinic expansion. The business provided ketamine-assisted psychotherapy services rather than a traditional drug-development pipeline, placing it in the healthcare delivery segment of the psychedelic therapeutics market. Its clinical focus appears to have included addiction and broader mental health conditions commonly treated in ketamine-assisted psychotherapy settings. The entity is best understood as an acquired operating clinic/business unit within Awakn's care-delivery strategy rather than as a standalone biotech R&D company.